LifeStance Health reported a gross margin of 35.15% and a net margin of 5.42% for the quarter ended Jun 2026. These financial ratios cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||
| Gross Margin | 31.53% | 31.31% | 32.12% | 33.62% | 32.97% | 31.40% | 32.04% | 33.04% | 33.69% | 35.15% | |||||||||||||||
| EBT Margin | -74.33% | -62.44% | -33.98% | -32.36% | -19.40% | -23.42% | -15.15% | -20.04% | -29.66% | -13.65% | -6.90% | -7.24% | -1.72% | -2.73% | -0.44% | -1.72% | 1.26% | 3.98% | 4.90% | 6.31% | |||||
| EBIT Margin | -71.72% | -59.87% | -31.93% | -28.86% | -17.85% | -20.06% | -13.50% | -18.65% | -28.28% | -11.50% | -5.58% | -5.11% | 0.02% | 0.33% | 0.48% | -0.85% | 2.04% | 4.73% | 5.52% | 7.04% | |||||
| EBITDA Margin | -71.72% | -59.87% | -31.93% | -28.86% | -17.85% | -20.06% | -13.50% | -18.65% | -28.28% | -11.50% | -5.58% | -5.11% | 0.02% | 0.33% | 0.48% | -0.85% | 2.04% | 4.73% | 5.52% | 7.04% | |||||
| Operating Margin | -71.72% | -59.87% | -31.93% | -28.86% | -17.85% | -20.06% | -13.50% | -18.65% | -28.28% | -11.50% | -5.58% | -5.11% | 0.02% | 0.33% | 0.48% | -0.85% | 2.04% | 4.73% | 5.52% | 7.04% | |||||
| Net Margin | -69.29% | -56.86% | -30.69% | -32.80% | -17.40% | -20.34% | -13.56% | -17.52% | -23.42% | -16.02% | -7.02% | -7.45% | -1.90% | -2.19% | 0.21% | -1.10% | 0.30% | 3.05% | 3.53% | 5.42% | |||||
| FCF Margin | -4.23% | -12.11% | -8.61% | -4.31% | 11.13% | -6.18% | -4.63% | -13.37% | 1.92% | -8.97% | 12.47% | 5.65% | 17.21% | -3.08% | 16.40% | 4.67% | 12.21% | 5.54% | 20.19% | ||||||
| Efficiency | |||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1,914.59M | 1,920.93M | 1,942.75M | 1,963.53M | 1,974.17M | 2,076.77M | 2,166.22M | 2,164.74M | 2,172.99M | 2,142.52M | 2,108.14M | 2,112.83M | 2,113.65M | 2,113.12M | 2,111.49M | 2,125.74M | 2,147.89M | 2,176.45M | 2,174.91M | 2,163.69M | |||||
| Invested CapitalInvested Cap. | 14.01M | 14.12M | 13.49M | 8.98M | 10.82M | 15.88M | 13.26M | 10.54M | 8.96M | 8.17M | 4.45M | 3.81M | 2.50M | ||||||||||||
| Asset Utilization RatioAsset Util. | 0.33 | 0.35 | 0.37 | 0.40 | 0.42 | 0.41 | 0.42 | 0.44 | 0.46 | 0.49 | 0.52 | 0.55 | 0.57 | 0.59 | 0.61 | 0.62 | 0.64 | 0.65 | 0.69 | 0.73 | |||||
| Leverage & Solvency | |||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -35.59 | -31.58 | -18.85 | -8.48 | -9.27 | -8.91 | -6.70 | -9.46 | -13.58 | -5.83 | -2.84 | -2.74 | 0.01 | 0.11 | 0.52 | -1.02 | 2.63 | 6.29 | 12.43 | 11.65 | |||||
| Debt Ratio | 0.09 | 0.09 | 0.10 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.14 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | |||||
| Times Interest Earned | -35.59 | -31.58 | -18.85 | -8.48 | -9.27 | -8.91 | -6.70 | -9.46 | -13.58 | -5.83 | -2.84 | -2.74 | 0.01 | 0.11 | 0.52 | -1.02 | 2.63 | 6.29 | 12.43 | 11.65 | |||||
| Valuation | |||||||||||||||||||||||||
| Price to EarningsP/E | -0.04 | -0.03 | -0.06 | -0.03 | -0.06 | -0.04 | -0.08 | -0.07 | -0.04 | -0.06 | -0.11 | -0.08 | -0.43 | -0.38 | 3.45 | -0.50 | 1.88 | 0.22 | 0.16 | 0.17 | |||||
| Price to SalesP/S | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
| Price to BookP/B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Enterprise Value | -207.14M | -144.91M | -110.44M | -94.72M | -87.97M | -106.87M | -65.61M | -76.29M | -40.05M | -75.95M | -47.18M | -85.16M | -100.04M | -151.86M | -131.89M | -187.03M | -201.88M | -246.06M | -192.46M | -222.01M | |||||
| EV to EBIT | 1.66 | 1.27 | 1.70 | 1.57 | 2.26 | 2.32 | 1.92 | 1.58 | 0.54 | 2.35 | 2.81 | 5.34 | -0.00M | -143.40 | -82.22 | 63.40 | -27.24 | -13.61 | -8.64 | -7.24 | |||||
| EV to EBITDA | 1.66 | 1.27 | 1.70 | 1.57 | 2.26 | 2.32 | 1.92 | 1.58 | 0.54 | 2.35 | 2.81 | 5.34 | -0.00M | -143.40 | -82.22 | 63.40 | -27.24 | -13.61 | -8.64 | -7.24 | |||||
| Market Capitalization | 4.98M | 3.12M | 3.55M | 1.97M | 2.37M | 1.76M | 2.68M | 3.32M | 2.56M | 2.88M | 2.27M | 1.80M | 2.57M | 2.71M | 2.45M | 1.90M | 2.02M | 2.59M | 2.34M | 3.94M | |||||
| Price to FCFP/FCF | -0.39 | -0.14 | -0.11 | -0.25 | 0.07 | -0.17 | -0.28 | -0.07 | 0.53 | -0.08 | 0.05 | 0.15 | 0.05 | -0.24 | 0.03 | 0.12 | 0.06 | 0.10 | 0.04 | ||||||
| EV to FCF | 18.02 | 4.49 | 5.25 | 9.39 | -4.19 | 4.20 | 6.35 | 1.14 | -14.11 | 1.75 | -2.19 | -5.66 | -2.71 | 12.85 | -3.30 | -11.88 | -5.27 | -8.61 | -2.53 | ||||||
| EV to CFO | -4.73 | -33.39 | -12.09 | -15.35 | -2.98 | 8.32 | 175.78 | 1.58 | -4.52 | 2.16 | -1.93 | -4.40 | -2.44 | 42.65 | -2.90 | -7.40 | -4.27 | -5.81 | -2.22 | ||||||
| Return Ratios | |||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Return on Capital Employed [ROCE]ROCE | -9.38% | -15.87% | -19.28% | -19.64% | -14.93% | -11.06% | -9.04% | -8.44% | -10.50% | -9.75% | -9.04% | -7.39% | -3.43% | -1.68% | -0.70% | -0.01% | 0.37% | 1.25% | 2.32% | 4.15% | |||||
| Return on Invested Capital [ROIC]ROIC | -0.05% | -0.06% | -0.06% | -0.06% | -0.04% | -0.03% | -0.03% | -0.02% | -0.03% | -0.03% | -0.04% | -0.04% | -0.02% | -0.02% | -0.01% | 0.00% | |||||||||
| Return on Assets [ROA]ROA | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |